# Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

> **NCT05066412** · PHASE1 · RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 12 (estimated)

## Conditions studied

- Hematologic Malignancy
- Haplo-identical Stem Cell Transplantation

## Interventions

- **OTHER:** CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology

## Key facts

- **NCT ID:** NCT05066412
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-26
- **Primary completion:** 2026-06-02
- **Final completion:** 2026-12-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066412, "Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05066412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*